#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive Hereditary ataxia Lennox-Gastaut syndrome Phenylketonuria Fibrous dysplasia of bone Superficial vein thrombosis Tourette's disorder Frostbite Myelodysplastic syndrome Uveitis Drug eruption Narcolepsy Neonatal alloimmune thrombocytopenia Uterine leiomyosarcoma Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Treatment Myelodysplastic syndrome – Trials in Disease Retinoblastoma – Diagnostics Synovial sarcoma Glycogen storage disease type I – Life with Disease Haemophilia B without inhibitors – Trials in Disease Fragile X syndrome – Diagnostics Gaucher’s disease type I Ocular melanoma – Treatment Glomerulonephritis rapidly progressive – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bupivacaine Hydrochloride Benserazide Hydrochloride Abelacimab Repotrectinib Bgb-15025 Citrate Specific Nucleic Acid Sna-Her1 A/(H3N2)-LIKE VIRUS ANTIGEN Emraclidine Corylus Avellana L. Soya Oil, Purified Promethazine Hydrochloride Avb-101 Dog Epithelium Extract Vibostolimab Gallium (68Ga) Gozetotide VHB937 Avalotcagene Ontaparvovec Idursulfase Tecovirimat Rocatinlimab More therapies…

    Learn about Your Condition

    Systemic lupus erythematosus Piriformis syndrome Hypersomnia Cholangiocarcinoma Adenovirus infection Eye inflammation Wheezing Hyperglycaemia Metastases to lymph nodes Cardiac failure Kawasaki's disease Medication overuse headache COVID-19 Peritoneal cancer index KBG syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Risankizumab for Children Aged 6-17 With Moderate to Severe Plaque Psoriasis After Completing Previous Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Risankizumab
    Germany Poland Spain

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France

  • Study on Nalmefene and Placebo for Reducing Cravings in Patients with Gambling Disorder, Sexual Addiction, or Food Addiction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Behavioural addiction
    France

  • Study on the Safety and Effects of ACI-24.060 for Patients with Early Alzheimer’s Disease and Adults with Down Syndrome

    Recruiting

    1 1 1
    Investigated Drugs:
    • Pal1-15 Acetate
    • Izaflortaucipir (18F)
    • Florbetaben (18F)
    Spain

  • Study on the Effectiveness of Dutasteride with Goserelin Acetate and Bicalutamide in Patients with Recurrent or Metastatic Salivary Duct Carcinoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Dutasteride
    • Bicalutamide
    • Goserelin Acetate
    The Netherlands
Previous Page
1 … 570 571 572 573 574 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!